April 1st 2025
Novavax’s COVID-19 vaccine, Merck’s RSV antibody, and Innoviva’s gonorrhea antibiotic await regulatory decisions this quarter.
CDC Responds to Rising Rates of Syphilis by Issuing Call to Action
May 4th 2017The rates of primary and secondary syphilis in the United States have increased by 19% from 2014 to 2015, and the CDC notes that preliminary data suggests that there was a “similar rate of increase in the first 6 months of 2016.”
Read More
Mutated HIV Proviruses Are Not as Harmless as Previously Thought
May 3rd 2017In a collaborative effort, scientists from Johns Hopkins School of Medicine and George Washington University have found that defective HIV proviruses can complicate monitoring the true viral load within patients and distract the immune system from attacking the functional virus.
Read More